Correlation between radiomic features of Crohn's disease and secondary loss of response to infliximab

doi:10.3748/wjg.v31.i27.109459

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (570)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

HTML

258

Figures (1-5)

Tables (1-3)

Sum=337

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

139

Sum=185

Publishing Process of This Article

Item

Count

Browse

Download

Sum=33

Jul 21, 2025 (publication date) through Jul 28, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jul 21, 2025; 31(27): 109459
Published online Jul 21, 2025. doi: 10.3748/wjg.v31.i27.109459

Full Size Figure Download Figure

Figure 4 Clinical-Radiomics nomogram. HBI: Harvey-Bradshaw Index; WBC: White blood cell.

Citation: Li S, Zhu C, Tong L, Zheng XM, Rong C, Gao YK, Yuan DC, Wu XW. Correlation between radiomic features of Crohn's disease and secondary loss of response to infliximab. World J Gastroenterol 2025; 31(27): 109459
URL: https://www.wjgnet.com/1007-9327/full/v31/i27/109459.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i27.109459